Contacts, documents and full notice history are available with a subscription.

Award Notice 1 notice 4 documents

SPE2D2-25-D-0003 - Methylphenidate HCL ER Tablets Contract SPE2D2-25-D-0003

Solicitation SPE2D2-25-D-0003 Copied Notice ID 6122d2ce1e814050af4585a88080e05b Copied DEPT OF DEFENSE — DLA TROOP SUPPORT

SAM.gov

Posted

Nov 20, 2025

Deadline

No deadline

Set-aside

None

NAICS

325412

PSC

6505

Summary

AI-generated · Nov 21, 2025

P0004 is being issued to exercise the first-year option for methylphenidate HCl ER tablets under the existing contract. The option has been awarded to SPECGX LLC for $4,154,058.30.

P0004 is being issued to exercise the first year option.

From Award Notice posted on Nov 20, 2025

Notice history

Award Notice LATEST Posted Nov 20, 2025

Details

Solicitation number SPE2D2-25-D-0003

Notice ID 6122d2ce1e814050af4585a88080e05b

Award number SPE2D2-25-D-0003

Notice type Award Notice

Product / Service (PSC) 6505

NAICS 325412

Archive date Dec 10, 2029

Award Information

Awardee

Total Awarded

$4,154,058.30

Award Date

Dec 10, 2024

Award Notices

SPE2D2-25-D-0003 - Methylphenidate HCL ER Tablets Contract View Notice

Posted: Nov 20, 2025

P0004 is being issued to exercise the first year option.

Awardees

Company Name	UEI	CAGE Code	Location
SPECGX LLC	SJ9MSB1UXGL8	84GK4	Webster Groves, MO

Documents

Document 1

Document 2

Document 3

Document 4

Contacts

primary

Courtney Hunter

Phone

secondary

Jason C. Wray

Phone

Agency

DEPT OF DEFENSE

DEFENSE LOGISTICS AGENCY

TROOP SUPPORT MEDICAL

DLA TROOP SUPPORT

Dates

Posted Nov 20, 2025 8 months ago

Last Updated Nov 22, 2025 8 months ago

Awarded Dec 10, 2024 1 year ago